Search

Carl J. Arbes

Examiner (ID: 12863, Phone: (571)272-4563 , Office: P/3729 )

Most Active Art Unit
3729
Art Unit(s)
3726, 2103, 3727, 3206, 3201, 3202, 3729, 2899, 2831
Total Applications
4677
Issued Applications
4193
Pending Applications
65
Abandoned Applications
435

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19792121 [patent_doc_number] => 12233044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-25 [patent_title] => Cannabidiol and chitosan compositions and methods of using the same [patent_app_type] => utility [patent_app_number] => 17/982745 [patent_app_country] => US [patent_app_date] => 2022-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 14610 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982745 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/982745
Cannabidiol and chitosan compositions and methods of using the same Nov 7, 2022 Issued
Array ( [id] => 18886361 [patent_doc_number] => 11865117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Pharmaceutical compositions comprising meloxicam [patent_app_type] => utility [patent_app_number] => 18/051656 [patent_app_country] => US [patent_app_date] => 2022-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 33 [patent_no_of_words] => 23915 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18051656 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/051656
Pharmaceutical compositions comprising meloxicam Oct 31, 2022 Issued
Array ( [id] => 18449497 [patent_doc_number] => 20230190773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => INHIBITION OF SLC TRANSPORTER ACTIVITY OR EXPRESSION TO ATTENUATE ANTHRACYCLINE-INDUCED CARDIOTOXICITY [patent_app_type] => utility [patent_app_number] => 18/051386 [patent_app_country] => US [patent_app_date] => 2022-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28169 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18051386 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/051386
Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity Oct 30, 2022 Issued
Array ( [id] => 18285049 [patent_doc_number] => 20230100521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => COMPOSITIONS CONTAINING INOSITOL-STABILIZED ARGININE SILICATE COMPLEXES AND INOSITOL FOR IMPROVING COGNITIVE FUNCTION IN VIDEO GAMERS [patent_app_type] => utility [patent_app_number] => 17/959661 [patent_app_country] => US [patent_app_date] => 2022-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4802 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959661 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/959661
COMPOSITIONS CONTAINING INOSITOL-STABILIZED ARGININE SILICATE COMPLEXES AND INOSITOL FOR IMPROVING COGNITIVE FUNCTION IN VIDEO GAMERS Oct 3, 2022 Abandoned
Array ( [id] => 19401393 [patent_doc_number] => 20240284904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => Antibacterial Composition [patent_app_type] => utility [patent_app_number] => 18/563694 [patent_app_country] => US [patent_app_date] => 2022-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4575 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 360 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563694 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563694
Antibacterial Composition Sep 27, 2022 Pending
Array ( [id] => 20076225 [patent_doc_number] => 12350259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-08 [patent_title] => Methods of treating migraine [patent_app_type] => utility [patent_app_number] => 17/953536 [patent_app_country] => US [patent_app_date] => 2022-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11713 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17953536 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/953536
Methods of treating migraine Sep 26, 2022 Issued
Array ( [id] => 18525463 [patent_doc_number] => 11712441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-01 [patent_title] => Pharmaceutical compositions comprising meloxicam [patent_app_type] => utility [patent_app_number] => 17/930272 [patent_app_country] => US [patent_app_date] => 2022-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 35 [patent_no_of_words] => 24933 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930272 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/930272
Pharmaceutical compositions comprising meloxicam Sep 6, 2022 Issued
Array ( [id] => 18208081 [patent_doc_number] => 20230054339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => COMPOSITIONS AND METHODS OF MODULATING S-NITROSYLATION [patent_app_type] => utility [patent_app_number] => 17/899121 [patent_app_country] => US [patent_app_date] => 2022-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16230 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17899121 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/899121
Compositions and methods of modulating S-nitrosylation Aug 29, 2022 Issued
Array ( [id] => 18107860 [patent_doc_number] => 20230000740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => ALCOHOL BASED SANITIZER WITH IMPROVED DERMAL COMPATIBILITY AND FEEL [patent_app_type] => utility [patent_app_number] => 17/822039 [patent_app_country] => US [patent_app_date] => 2022-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9889 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822039 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/822039
Alcohol based sanitizer with improved dermal compatibility and feel Aug 23, 2022 Issued
Array ( [id] => 18075821 [patent_doc_number] => 20220401433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate [patent_app_type] => utility [patent_app_number] => 17/888356 [patent_app_country] => US [patent_app_date] => 2022-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39508 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888356 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/888356
Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate Aug 14, 2022 Abandoned
Array ( [id] => 18619099 [patent_doc_number] => 11752121 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-12 [patent_title] => SmartCore compositions and methods [patent_app_type] => utility [patent_app_number] => 17/886354 [patent_app_country] => US [patent_app_date] => 2022-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4363 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886354 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/886354
SmartCore compositions and methods Aug 10, 2022 Issued
Array ( [id] => 18018939 [patent_doc_number] => 20220370438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => METHOD FOR INDUCING A SUSTAINED IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 17/881875 [patent_app_country] => US [patent_app_date] => 2022-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881875 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/881875
METHOD FOR INDUCING A SUSTAINED IMMUNE RESPONSE Aug 4, 2022 Abandoned
Array ( [id] => 18034488 [patent_doc_number] => 20220378703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => IMMEDIATE RELEASE FORMULATIONS OF CANNABINOIDS [patent_app_type] => utility [patent_app_number] => 17/880420 [patent_app_country] => US [patent_app_date] => 2022-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7536 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17880420 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/880420
Immediate release formulations of cannabinoids Aug 2, 2022 Issued
Array ( [id] => 18337464 [patent_doc_number] => 20230129413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => Levodopa and Carbidopa Intestinal Gel and Methods of Use [patent_app_type] => utility [patent_app_number] => 17/817191 [patent_app_country] => US [patent_app_date] => 2022-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817191 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/817191
Levodopa and Carbidopa Intestinal Gel and Methods of Use Aug 2, 2022 Abandoned
Array ( [id] => 18716468 [patent_doc_number] => 11793789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrine [patent_app_type] => utility [patent_app_number] => 17/871924 [patent_app_country] => US [patent_app_date] => 2022-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49288 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871924 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/871924
Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrine Jul 22, 2022 Issued
Array ( [id] => 18491505 [patent_doc_number] => 11696910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-11 [patent_title] => Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof [patent_app_type] => utility [patent_app_number] => 17/871920 [patent_app_country] => US [patent_app_date] => 2022-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49272 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 274 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871920 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/871920
Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof Jul 22, 2022 Issued
Array ( [id] => 18162623 [patent_doc_number] => 20230029216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => METHOD FOR TREATING SICKLE CELL DISEASE USING QUERCETIN-CONTAINING COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/865609 [patent_app_country] => US [patent_app_date] => 2022-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9135 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17865609 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/865609
Method for treating sickle cell disease using quercetin-containing compositions Jul 14, 2022 Issued
Array ( [id] => 18148589 [patent_doc_number] => 20230022446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer [patent_app_type] => utility [patent_app_number] => 17/863967 [patent_app_country] => US [patent_app_date] => 2022-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863967 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/863967
Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer Jul 12, 2022 Abandoned
Array ( [id] => 18842590 [patent_doc_number] => 20230404994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => MARKERS OF TISSUE AGING AND USES THEREFOR [patent_app_type] => utility [patent_app_number] => 17/860246 [patent_app_country] => US [patent_app_date] => 2022-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12021 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860246 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/860246
MARKERS OF TISSUE AGING AND USES THEREFOR Jul 7, 2022 Abandoned
Array ( [id] => 19903045 [patent_doc_number] => 12280029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-22 [patent_title] => Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators [patent_app_type] => utility [patent_app_number] => 17/833315 [patent_app_country] => US [patent_app_date] => 2022-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 2135 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833315 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/833315
Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators Jun 5, 2022 Issued
Menu